Skip to main content

Latest SEC Filings — Page 104

Most recent SEC EDGAR filings across all covered tickers, sorted chronologically. Wiseek AI reads each filing and scores it 1–10 for market-moving potential; click through for full analysis.

How Wiseek curates this list

Every filing on this page is sourced directly from SEC EDGAR, the U.S. Securities and Exchange Commission's public filings system. Wiseek processes 8-K, 10-K, 10-Q, Form 4, Form 144, DEF 14A, Schedule 13D/A and related disclosures filed by U.S.-listed companies. The original filing is always linked from each article so readers can verify the source document directly.

How filings get scored

Each filing runs through Wiseek's importance scorer, which weights filing type, deal magnitude, insider participation, material-event flags (going-concern, restatements, executive transitions, M&A) and historical market-reaction patterns. Filings scoring below 7 on the 1–10 scale are filtered out at the database query so this list stays focused on market-moving disclosures. See our methodology for the full rubric.

Editorial standards

Wiseek does not edit the underlying SEC filing. Plain-English summaries and key-event extractions are generated from the verified source text and clearly attributed as AI-generated. Wiseek does not provide investment advice — see our editorial policy for full standards on accuracy, source disclosure, and corrections.

Track by company

Follow all SEC filings for a specific company by visiting its ticker page: AAPL, MSFT, NVDA, TSLA, AMZN, GOOGL, META, JPM, V, UNH, XOM, AVGO, LLY, MA, COST, JNJ, PG, HD, ABBV, MRK, KO, NFLX, AMD, WMT, CVX, BAC — or browse all covered tickers.

Century Therapeutics Shareholders Approve 50% Increase in Authorized Common Stock
ProForm 8-KIPSC · Form 8-K · 13d ago
Soligenix Faces Nasdaq Delisting Threat and Terminates Lead Drug Program
ProForm 8-KSNGX · Form 8-K · 13d ago
Lipocine Re-Interprets Failed Phase 3 Data for LPCN 1154, Pursues NDA with FDA
ProForm 8-KLPCN · Form 8-K · 13d ago
SPAC Sets Shareholder Vote for Merger with Pre-Revenue Fusion Target; Warns of Going Concern Risk and Significant Dilution
ProForm 424B3SVAC · Form 424B3 · 13d ago
Officer Files Intent to Sell Shares Amidst Chapter 11 Bankruptcy Filing
Form 144SNBR · Form 144 · 13d ago
Silexion Therapeutics Registers Resale of 859,609 Shares for Selling Shareholders, Potential 76% Dilution
ProForm S-3SLXN · Form S-3 · 13d ago
Socket Mobile Removes CEO Kevin Mills, Appoints David A. Holmes Amidst Nasdaq Delisting Warning
ProForm 8-KSCKT · Form 8-K · 13d ago
Primary Refrigerant Facility Damaged by Storms, Operations Disrupted
ProForm 8-KHDSN · Form 8-K · 13d ago
Atara Biotherapeutics Appoints New Director, Approves 400K Share Equity Plan
Form 8-KATRA · Form 8-K · 13d ago
Arrive AI Launches $15M At-The-Market Offering Amidst Going Concern Warning
ProForm 8-KARAI · Form 8-K · 13d ago
Shareholders Approve 2.5M Share Increase for Incentive Plan
ProForm 8-KGIII · Form 8-K · 13d ago
SPAC Secures Extension with Extremely Low Redemptions, Bolstering Ace Green Recycling Merger
ProForm 8-KATEKU · Form 8-K · 13d ago
KALA BIO Amends $350M Shelf Registration to Reflect 1-for-50 Reverse Stock Split
Form S-3/AKALA · Form S-3/A · 13d ago
Avis Budget Group Issues $685.75M in Asset-Backed Securities for Fleet Financing
ProForm 8-KCAR · Form 8-K · 13d ago
La Rosa Holdings Faces New Nasdaq Delisting Threat Over Negative Equity
ProForm 8-KLRHC · Form 8-K · 13d ago
Major Shareholder Sells $23M in Redwire Stock via Cashless Warrant Exercise
Form 4RDW · Form 4 · 13d ago
Shareholders Approve Massive Dilution, Reverse Stock Split, and $11M Private Placement
ProForm 8-KAIHS · Form 8-K · 13d ago
Aardvark Therapeutics Awards $703.5K in Retention Bonuses to CFO/COO and CMO Amidst Clinical Hold
Form 8-KAARD · Form 8-K · 13d ago
Shareholders Approve Expanded Stock Incentive Plan, Increasing Potential Dilution
ProForm 8-KXLO · Form 8-K · 13d ago
BrightSpring Appoints Stanford AI & Data Science Expert Dr. Nigam Shah to Board
Form 8-KBTSG · Form 8-K · 13d ago
Shareholders Reject Officer Exculpation Amendment
Form 8-KAMSF · Form 8-K · 13d ago
Forbright, Inc. Completes $142.2M Initial Public Offering
ProForm 8-KFRBT · Form 8-K · 13d ago
Tokyo Lifestyle Reports Strong Sales Growth, Proposes Significant Year-End Dividend
ProForm 6-KTKLF · Form 6-K · 13d ago
Shareholders Approve Dual-Class Structure, 10 Billion Authorized Shares, and Reverse Split Authority
ProForm 6-KFOFO · Form 6-K · 13d ago
Shareholders Approve Amended Stock Plan, Authorizing 2.4 Million Additional Shares
Form 8-KANGI · Form 8-K · 13d ago
Grayscale Near Trust Files Amended S-1 for NYSE Arca Listing and ETF Conversion
Form S-1/AGSNR · Form S-1/A · 13d ago
TAL Education Group Reports Strong FY2026 Financials, $644M Share Repurchases Amid Persistent China Regulatory & Geopolitical Risks
ProForm 20-FTAL · Form 20-F · 13d ago
Hooker Furnishings Returns to Profitability, Boosts Cash, and Eliminates Debt in Q1
ProForm 10-QHOFT · Form 10-Q · 13d ago
Brown-Forman Reports 17% EPS Decline, $132M Brand Impairments, and Weak 2027 Outlook
ProForm 10-KBFB · Form 10-K · 13d ago
Cyabra Receives Formal Nasdaq Delisting Notice for Minimum Bid Price and MVPHS Violations
ProForm 8-KCYAB · Form 8-K · 13d ago